Anaemia in kidney disease: harnessing hypoxia responses for therapy

Koury, Mark J., Haase, Volker H.·2015·Nature Reviews Nephrology
DOI 10.1038/nrneph.2015.82

Cited by (315)

Items 201–300 of 315

  1. Iron chelation and 2‐oxoglutarate‐dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1
    Oľga Babošová, Katarina Kapralova, Leona Raskova Kafkova, Vladimír Kořínek, Vladimír Divoký, Josef T. Prchal, Lucie Lanikova · 2019 · Journal of Cellular and Molecular Medicine
  2. Effects of Roxadustat on Erythropoietin Production in the Rat Body
    Yukiko Yasuoka, Yuichiro Izumi, Takashi Fukuyama, Haruki Omiya, Truyen Derek Pham, Hideki Inoue, Tomomi Oshima, Taiga Yamazaki, Takayuki Uematsu, Noritada Kobayashi et al. · 2022 · Molecules
  3. Endothelin A receptor antagonist attenuated renal iron accumulation in iron overload heme oxygenase-1 knockout mice
    Elizabeth B. Saurage, Parker R. Davis, Rachel Meek, David M. Pollock, Małgorzata Kasztan · 2022 · Canadian Journal of Physiology and Pharmacology
  4. TO MARKET, TO MARKET–2021: SMALL MOLECULES
    Erika Araujo, Ian M. Bell, Alexander J. Burckle, Dennis C. Koester, James R. Manning, Richard D. Caldwell, Georgette M. Castanedo, Samantha A. Green, Mingshuo Zeng, Laurent Debien et al. · 2022 · Medicinal chemistry reviews
  5. Transient Improvement in Erythropoiesis Is Achieved Via the Chaperone AHSP With Early Administration of Propranolol in Burn Patients
    Julia Walczak, Corinne Bunn, Pravesh Saini, Yuk Ming Liu, Anthony J. Baldea, Kuzhali Muthumalaiappan · 2020 · Journal of Burn Care & Research
  6. Hematobiochemical variability and predictors of new-onset and persistent postpartum preeclampsia
    Linda Ahenkorah Fondjo, Beatrice Amoah, John Jude Kweku Annan, Enoch Appiah Adu‐Gyamfi, Evans Adu Asamaoh · 2022 · Scientific Reports
  7. Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States
    Glenn Matthew Chertow, Kai‐Uwe Eckardt, Mark J. Sarnak, Wolfgang C. Winkelmayer­, Rajiv Agarwal, Todd Eric Minga, Wenli Luo, Steven K. Burke · 2025 · Journal of the American Society of Nephrology
  8. Global, regional and national epidemiology of anemia attributable to chronic kidney disease, 1990–2021
    Wenli Liu, Wenhua Gu, Junhui Chen, Ruobing Wang, Yaohua Shen, Zhaoyu Lu, Lei Zhang · 2025 · Clinical Kidney Journal
  9. Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge
    José María Portolés, Rainer W. Oberbauer, Michele Freerk Eisenga, Aleix Cases, Jolanta Małyszko, Gabriel J. Choukroun, Marta Crespo, Kai‐Uwe Eckardt, Roberto Minutolo · 2025 · Clinical Kidney Journal
  10. Current research on the HIF-2α-EPO–Hb axis in hypoxic environments: from molecular mechanisms to clinical
    Qiaochu Zheng, Yinglan Li, Jimei Li · 2026 · Frontiers in Medicine
  11. Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island
    Laurel Romano, Katie Giger Seu, Lionel Blanc, Theodosia A. Kalfa · 2023 · Current Opinion in Hematology
  12. Reconsideration of the anemia management strategy for chronic kidney disease and dialysis patients
    Shoichiro Daimon · 2025 · Renal Replacement Therapy
  13. Bibliometric analysis of hypoxia inducible factor prolyl hydroxylase inhibitor in anemia
    Li Zheng, Ming Liu, Yatong Zhang, Kaihua Zhang, Yanting Gu, Deping Liu · 2022 · Frontiers in Pharmacology
  14. Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation
    Antonio Bouthelier, Lucía Fernández-Arroyo, C. Mesa-Ciller, D. Cibrian, N. Martín-Cófreces, Raquel Castillo-González, M. Calero, D. Herráez-Aguilar, Andrea Guajardo-Grence, Ana María Pacheco et al. · 2022 · iScience
  15. The protective effect and mechanism of piperazine ferulate in rats with 5/6 nephrectomy-caused chronic kidney disease
    Xiumeng Zhang, Xin-Ran Min, Dan Li, Bo Li, Yixin Rui, Hong-Xiao Xie, Rong Liu, Nan Zeng · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  16. Prolyl Hydroxylase Domain Protein Inhibitor Not Harboring a 2-Oxoglutarate Scaffold Protects against Hypoxic Stress
    Kento Sonoda, Sudarma Bogahawaththa, Akito Katayama, Saki Ujike, Sae Kuroki, Naho Kitagawa, Kohichi Hirotsuru, Norio Suzuki, Toshio Miyata, Shin-ichi Kawaguchi et al. · 2022 · ACS Pharmacology & Translational Science
  17. Characteristics of Japanese patients with non-dialysis-dependent chronic kidney disease initiating treatment for anemia: a retrospective real-world database study
    Yoshimasa Kokado, Manabu Ishii, Kiichiro Ueta, Hiroyuki Yamamoto, Hiraku Kumamaru, Masaaki Isshiki, Sven Demiya, Hiroaki Miyata · 2022 · Current Medical Research and Opinion
  18. Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease
    Nava Yugavathy, Bashar Mudhaffar Abdullah, Soo Kun Lim, Abdul Halim Abdul Gafor, Muh Geot Wong, Sunita Bavanandan, Hin Seng Wong, Hasniza Zaman Huri · 2023 · Current Issues in Molecular Biology
  19. Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy
    Umesh Chandra Halder · 2018 · Journal of Biological Research - Thessaloniki
  20. ARNT as a Novel Antifibrotic Target in CKD
    Volker H. Haase · 2018 · American Journal of Kidney Diseases
  21. Anemia in Chronic Kidney Disease
    Isabella Guzzo, Meredith A. Atkinson · 2022 · Springer eBooks
  22. Kidney involvement and anemia in COVID-19 infection
    Guido Gembillo, Luigi Peritore, Giuseppe Spadaro, Felicia Cuzzola, Michela Calderone, Rossella Messina, Simona Di Piazza, Flavia Sudano, Maria Elsa Gambuzza, Maria Princiotto et al. · 2025 · World Journal of Nephrology
  23. Mendelian Randomization Analysis of Systemic Iron Status and Risk of Different Types of Kidney Disease
    Jiahui Zhou, Wanting Shi, Dongya Wu, Shujie Wang, Xinhui Wang, Junxia Min, Fudi Wang · 2024 · Nutrients
  24. Insoluble HIFa protein aggregates by cadmium disrupt hypoxia-prolyl hydroxylase (PHD)-hypoxia inducible factor (HIFa) signaling in renal epithelial (NRK-52E) and interstitial (FAIK3-5) cells
    Timm Schreiber, Bettina Scharner, Frank Thévenod · 2024 · BioMetals
  25. The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review
    Yousuf Abdulkarim Waheed, Jie Liu, Shifaa Almayahe, Dong Sun · 2024 · Frontiers in Nephrology
  26. Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan
    Masaomi Nangaku, Kazuyo Sasaki, Jing Bi, Kiichiro Ueta, Kenichi Nishimura, Takafumi Hashimoto, Mihoko Hata · 2025 · Advances in Therapy
  27. Discovery and characterization of a novel HIF-2α agonist for the treatment of CKD-related renal anemia
    Shu-qing Chu, Yijie Chen, Ruirui Yang, Dan Teng, Guizhen Zhou, Yingying Zhang, Bu-ying Niu, Jia-Hang Xu, Kexin Lin, Xinyu Yang et al. · 2025 · Acta Pharmacologica Sinica
  28. Acupuncture for Anaemia and Large Intestine Impaction Associated with Hind Limb Weakness in a Horse: A Case Report
    María Resano-Zuazu · 2020 · Journal of Acupuncture and Meridian Studies
  29. Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study
    Yu‐Shan Huang, Mingfeng Li, Mei‐Chen Lin, Shih‐Hsiang Ou, Jen‐Hung Wang, Chien‐Wei Huang, Kang‐Ju Chou, Hua-Chang Fang, Po‐Tsang Lee, Chih‐Yang Hsu et al. · 2022 · Clinical and Translational Science
  30. Anemia in Pediatric Kidney Transplant Recipients—Etiologies and Management
    Anne M. Kouri, Shanthi S. Balani, Sarah J. Kizilbash · 2022 · Frontiers in Pediatrics
  31. A Comprehensive Description of Hypoxia-inducible Factor 2α Inhibitors as Anticancer Agents: A Mini-review
    Hongyuan Lu, Yan Zhu, Wenwu Liu, Yuanyuan Yan, Xiaowen Jiang, Qinbiao Wang, Yanyun Zhao, Miao He, Minjie Wei · 2022 · Current Medicinal Chemistry
  32. Erythrocytes A New/Old Target for Hypoxia in Chronic Kidney Disease?
    Leslie S. Gewin · 2020 · Circulation Research
  33. Hypoxia-inducible factor prolyl 4-hydroxylase-2 in Tibetan high-altitude adaptation, extramedullary erythropoiesis and skeletal muscle ischemia
    Mikko Myllymäki · 2016
  34. Erythropoiesis-stimulating agent responsiveness and hemoglobin variability is associated with fat tissue index in hemodialysis patients with darbepoetin-alfa treatment: a prospective observational cohort study
    Hyokyeong Yu, Dong-Jin Oh, Do Hyoung Kim · 2024 · Kidney Research and Clinical Practice
  35. Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050
    Yifan Li, Liting Gao, Yixuan Chen, J W Wang, Zhenjie Hu, Tian Zhao, Hongjun Tian, Deguang Wang, Wenbin Wang, Danfeng Zhang · 2025 · Nephrology Dialysis Transplantation
  36. Successful treatment of anti-EPO antibody associated refractory anemia with hypoxia-inducible factor prolyl hydroxylase inhibitor
    Huifang Zhang, Zineng Huang, Liyu He, Fang Yuan, Lin Sun, Fuyou Liu, Li Xiao · 2020 · Renal Failure
  37. Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
    Wenhui Wu, Nan Hu, Xiurong Li, Jia Di, Hua Zhou, Hongyan Niu, Min Yang · 2024 · Renal Failure
  38. The haemato-protective effect of Piliostigma thonningii leaf extract on indomethacin-induced gastric mucosa ulcer in rats
    Atamgba Agbor Asuk, K Dasofunjo, M. N. Ugwu, F. O. Adie · 2018 · International Journal of Basic & Clinical Pharmacology
  39. Got glycogen? An energy resource in HIF-mediated prevention of ischemic kidney injury
    Volker H. Haase · 2020 · Kidney International
  40. Evaluation of switching treatment from high dose of darbepoetin to lower dose of roxadustat in Japanese hemodialysis patients
    Reo Kanda, Ayano Kubo, Takuto Seki, Atsuko Urita, Makiho Sekiuchi, Yasuhiko Tomino · 2021 · Therapeutic Apheresis and Dialysis
  41. Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia
    Yan Cui, Hui Li, Sijiu Yu, Seth Yaw Afedo, Xuefeng Bai · 2022 · Journal of Molecular Histology
  42. Recent advances in CKD and ESRD: A literature update
    Tushar Chopra, Mitchell Howard Rosner · 2016 · Hemodialysis International
  43. Bridging the Gap Between CKD Management Paradigms in Transplant and Nontransplant Settings: Published Evidence, Challenges, and Perspectives
    Inès Dufour, Elliott Van Regemorter, Nada Kanaan, Antoine Buemi, Tom Darius, Michel Mourad, Eric Jean Goffin, Michel Y. Jadoul, Arnaud Devresse, Valentine Gillion · 2024 · Transplantation
  44. Effect of histidine and carnosine on haemoglobin recovery in anaemia induced-kidney damage and iron-loading mouse models
    Mayra Vera‐Aviles, Jorge Moreno‐Fernández, Tugba Kose, Robert C. Hider, Gladys Oluyemisi Latunde-Dada · 2025 · Amino Acids
  45. Baseline cardio-kidney-metabolic syndrome, its transition, and frailty: insights from the China Health and Retirement Longitudinal Study (CHARLS)
    Ruixue Duan, Z Y Li, Xuhui Li, Wenxia Ren, Jiaojiao Li, Yajing Bai, Angxian Lü, Yuanyuan Yan, Anqi Zhao, Shiwei Liu · 2026 · European journal of medical research
  46. Navigating Anemia Therapy in CKD With Hypoxia-Inducible Factor Activators: A Review
    Volker H. Haase, Nadiesda A. Costa, Mark J. Koury · 2026 · American Journal of Kidney Diseases
  47. SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism
    Elmukhtar Habas, Amnna Rayani, Ala Habas, Khaled Alarbi, Aml Habas, Mohamed Baghi, Eshrak Habas, Elmehdi Errayes, Abdelrahaman Hamad, Abdelnaser Elzouki · 2026 · Renal Failure
  48. Anaemia and Antianaemic Medications
    Gudisa Bereda · 2022 · Pharmaceutics and Pharmacology Research
  49. Development of a health economic model to evaluate the cost-effectiveness of roxadustat in treating anemia associated with non-dialysis-dependent chronic kidney disease
    Maria Mata Lorenzo, Mahmood Ali, Stuart Mealing, Joe W. E. Moss · 2023 · Journal of Medical Economics
  50. Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease
    Mrittika Roy, Shaifali Saroha, Uddipan Sarma, Harini Sarathy, Rukmini Kumar · 2023 · Frontiers in Pharmacology
  51. Anemia in Children with Chronic Kidney Disease
    Mohamed S. Al Riyami · 2024 · Asian Journal of Pediatric Nephrology
  52. Erythropoietin as a critical prognostic indicator in ICU patients with sepsis: a prospective observational study
    Qianping Zhang, Yan Zhang, Xin-Yi Tian, Kaifan Lin, Jie Weng, Xiaolong Fu, Yongjie Chen, Xuemeng Li, Bihuan Cheng, Xiaolong Zhang et al. · 2025 · Journal of Intensive Care
  53. Anemia in Chronic Kidney Disease
    Isabella Guzzo, Meredith A. Atkinson · 2021 · Springer eBooks
  54. Hypoxia: from basic mechanisms to therapeutics – a meeting report on the Keystone and HypoxiaNet Symposium
    Carsten C. Scholz, Karen Nolan · 2015 · Hypoxia
  55. Thoracic Osteomyelitis and Eustachian Valve Endocarditis: A Case Report and Literature Review
    Sheila D Hernandez, Maxwell J Jabaay, Dario Alfredo Marotta, Ravitej Goteti, William D Hewitt, Arash Velayati · 2021 · Cureus
  56. Correlation of Reticulocyte Hemoglobin Equivalent (Ret-He) Levels and Iron Deficiency Anemia in CKD Patients Treating Regular Hemodialysis
    Husni Gunawan Hasibuan, Syafrizal Nasution, Radar Radius Tarigan · 2021 · International Journal of Research and Review
  57. The prolyl hydroxylase inhibitor molidustat fails to restore erythropoietin production in the fibrotic kidney
    Gunnar Schley, Andrea Hartner · 2022 · Acta Physiologica
  58. Anemia
    Kathleen E. Altemose, Meredith A. Atkinson · 2022
  59. Revolutionizing anemia management in dialysis: unveiling the potential of FDA-approved Vadadustat for chronic kidney disease (CKD) patients
    Muhammad Hamza Gul, Aiman Waheed, Mayank Jha, Abdul Baseer Wardak, Badr Ilma, Umer Khan · 2025 · Annals of Medicine and Surgery
  60. Hypoxia-inducible factor 2α overexpression in podocytes ameliorates lipid metabolism disorders in diabetic kidney disease by inhibiting S1P
    Xue Yang, Qimeng Wang, Huibin Nie, Mingming Wang, Yinghui Wang, Shan Li, Qingzhen Liu, Gang Liu · 2025 · Renal Failure
  61. Real-world use of HIF-PH inhibitors in the Japan dialysis outcomes and practice patterns study (J-DOPPS, 2019–2022)
    Masahiro Eriguchi, Kazuhiko Tsuruya, Hisashi Noma, Yoshihiro Onishi, Masami Inuzuka, Kenji Harada, Masaomi Nangaku · 2026 · BMC Nephrology
  62. Consideration of structural and functional entities of modern biology under the Ayurvedic concept of Dhatu
    V. Bharatiya, Shruti Phatak · 2026 · Journal of Research in Ayurvedic Sciences
  63. Management of Anemia in Children Receiving Chronic Dialysis
    Meredith A. Atkinson, Bradley A. Warady · 2021 · Springer eBooks
  64. Anemia Management
    Bradley A. Warady · 2017 · Springer eBooks
  65. Improving lipophilicity of 5-(1-acetyl-5-phenylpyrazolidin-3-ylidene)-1,3-dimethylbarbituric acid increases its efficacy to activate hypoxia-inducible factors
    Kento Sonoda, Saki Ujike, Akito Katayama, Norio Suzuki, Shinichi Kawaguchi, Tadayuki Tsujita · 2022 · Bioorganic & Medicinal Chemistry
  66. Factors Related to the Occurrence of Anemia in Pre-Dialysis Chronic Kidney Disease Patients at Prof. Dr. I Goesti Ngoerah Gede Ngoerah Hospital, 2020-2022
    Ni Komang Ayu Amanda Setiari Jaya, I Gusti Ayu Widianti, Muliani . · 2024 · International Journal of Research and Review
  67. Home Haemoglobin Monitoring for the Titration of Erythropoietin-Stimulating Agents in Chronic Kidney Disease: A Pragmatic Pilot Trial
    Richard Bodington, Madeline Lok, Sunil Bhandari · 2024 · Diagnostics
  68. Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors
    Adam Myszczyszyn, Oliver Popp, Séverine Kunz, Anje Sporbert, Simone Jung, Louis C. Penning, Annika Fendler, Philipp Mertins, Walter Birchmeier · 2024 · PLoS ONE
  69. Effect of PTH on the Hematologic System
    Naoto Hamano, Hirotaka Komaba, Masafumi Fukagawa · 2020 · Springer eBooks
  70. Anemia in Chronic Kidney Disease
    Jeffrey S. Berns, Tiffany C. Wong, Solomon Dawson · 2018 · Elsevier eBooks
  71. Peculiarities of progression of chronic glomerulonephritis associated with anemia
    Ilkhom T. Murkamilov, К. А. Айтбаев, R.R. Kaliev Kaliev · 2016 · Clinical Medicine (Russian Journal)
  72. Eisenmangel bei chronischer Nierenerkrankung
    Severin Schricker, Moritz Schanz, Markus Ketteler · 2020 · Dialyse aktuell
  73. The insect response to climate change: Perspectives from the Quaternary record
    Allan Ashworth, Donald P. Schwert · 1993 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  74. Perbandingan efektivitas dan keamanan antara roxadustat dan epoetin alfa sebagai terapi anemia pada pasien yang menjalani hemodialisis reguler: meta analisis
    Kadek Wisnu Segara Karya, Ni Luh Parameswari Praptika, Nyoman Yudia Trianadewi Nurbudhi, Yenny Kandarini · 2021 · Intisari Sains Medis
  75. Faculty Opinions recommendation of Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience.
    Mitchell J. Weiss · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  76. Evaluation The Iron Homeostasis and Erythropoietic Activity in Male Rats with Anemia Related with Induced Chronic Renal Failure
    A. E.-M. N. Darweesh · 2020 · Indian Journal of Forensic Medicine & Toxicology
  77. NGAL as a biomarker in chronic kidney disease
    Ali Nahedh Abdulameer, Haider Salih Jaffat · 2022 · International Journal of Health Sciences
  78. 赤血球造血因子製剤と低酸素誘導因子水酸化酵素阻害薬の使い分け
    Hirokazu Honda · 2022 · Nihon Toseki Igakkai Zasshi
  79. Prolyl hydroxylase inhibitors, polydrug use, and the phosphoproteome
    Robert Labes, Kameliya Roegner · 2022 · Acta Physiologica
  80. Extremely Low Dose of Erythropoiesis-Stimulating Agent May Be Associated with Increased Mortality in Hemodialysis Patients
    Chengwen Yang, Mei‐Chen Lin, Kai-Hsiang Shu, Kuei‐Ting Tung, Wan‐Chuan Tsai, Ju‐Yeh Yang, Mei‐Fen Pai, Hon‐Yen Wu, Yen‐Ling Chiu, Yu‐Sen Peng et al. · 2023 · American Journal of Nephrology
  81. Interest of HIF stabilizers in home dialysis
    Guy Rostoker · 2023 · Bulletin de la Dialyse à Domicile
  82. Recombinant erythropoietin treatment improves serum podocyte marker levels in diabetic kidney disease
    Lingfeng Zeng, Jack Kit‐Chung Ng, Winston Wing‐Shing Fung, Gordon Chun‐Kau Chan, Kai Ming Chow, Cheuk‐Chun Szeto · 2023 · Advances in Biomarker Sciences and Technology
  83. A case study on the first-in-class antirenal anemia drug roxadustat
    Xiaojin Zhang, Qidong You · 2025 · Elsevier eBooks
  84. A Case of Cardiorenal Anemia Syndrome Complicated with Malignant Hypertension
    Xiaoyi Xu, Hong Cheng, Weijing Bian · 2025 · Springer eBooks
  85. Treatment of Renal Anemia in a Maintenance Hemodialysis Patient with Viral Hepatitis B Infection
    Li Chen, Wenxiu Chang · 2025 · Springer eBooks
  86. Treatment Progress of SGLT2 Inhibitors in Anemia of CKD
    润智 张 · 2025 · Advances in Clinical Medicine
  87. Burden of anemia in kidney transplant patients: Epidemiology, pathophysiology, and management
    Elmukhtar M. Habas, Amnna Rayani, Aml Habas, Gamal B. Alfitori, Ala M Habas, Kalifa Farfar, Eshrak Habas, Khaled Mohamed S Alarbi, Mohamed Abdunasser M. Baghi, Almehdi Errayes et al. · 2025 · Ukrainian Journal of Nephrology and Dialysis
  88. Metabolic reprogramming during ineffective erythropoiesis in β-thalassemia/HbE disease
    Chanyanat Sukhuma, Donny Nauphar, Khanita Nuamsee, Wasinee Kheansaard, Kittiphong Paiboonsukwong, Alisa Wilantho, Chumpol Ngamphiw, Pornthip Chaichompoo, Sissades Tongsima, Saovaros Svasti et al. · 2025 · Experimental and Molecular Pathology
  89. Structural, Thermodynamic, and Dynamic Descriptors for the Differential Mechanism of HIF-2 Activity Modulators
    Rajat Punia, Gaurav Goel · 2025 · Journal of Chemical Information and Modeling
  90. Desidustat for the Treatment of Anaemia in Adult End‐Stage Kidney Disease Patients on Maintenance Haemodialysis: A Prospective Observational Study
    Ankit Tiwari, Mahesan Niranjan, Karthik Kalidindi, Siddharth Herur, Anshul Dudani, Vijay Chander Bukka, Gangadhar Taduri, Swarnalatha Guditi · 2025 · International Journal of Nephrology
  91. Influence of volume overload on endogenous erythropoietin production in hemodialysis patients
    Shoichiro Daimon, Akihiko Koshino, Yasunori Iwata · 2025 · Research Square
  92. Two Cases of Giant Uterine Leiomyomas With Myomatous Erythrocytosis Syndrome Treated by Laparoscopic Hysterectomy
    Noritoshi Aimoto, Takashi Matsumoto, Yonosuke Tsuda, Yumi Hosokawa · 2025 · Cureus
  93. Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease–Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis‐Stimulating Agent Dose
    Alan G. Jardine, Steven K. Burke, Wei Feng Luo, Todd Eric Minga, Mark J. Sarnak, Wolfgang C. Winkelmayer­, Rajiv Agarwal, Glenn Matthew Chertow, Kai‐Uwe Eckardt, Mark J. Koury · 2025 · Hemodialysis International
  94. A-kinase anchoring protein 17 A promotes hypoxic adaptation and tumor growth by augmenting HIF1α protein synthesis
    Boqi Zhang, Zifan Wang, Yanfei Tang, Guanbo Ma, Yunzhang Liu, Yun Li, Jiejie Hao, Junli Ye, Xiangrong Sun, Ling Lu · 2025 · International Journal of Biological Macromolecules
  95. Additional file 1 of VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2α
    Jiayi Yang, Yuyi Ruan, Wang, Dan, Jinjin Fan, Ning Luo, Chen, Huiting, Li, Xiaoyan, Chen, Wei, Wang, Xin · 2022 · Figshare
  96. Additional file 1 of Nanoengineered injectable hydrogels derived from layered double hydroxides and alginate for sustained release of protein therapeutics in tissue engineering applications
    V.H. Giang Phan, Duong, Hai-Sang, Le, Quynh-Giao Thi, Janarthanan, Gopinathan, Sanjairaj Vijayavenkataraman, Nguyen, Hoang-Nam Huynh, Nguyen, Bich-Phuong Thi, Panchanathan Manivasagan, Eue‐Soon Jang, Li, Yi et al. · 2024 · Figshare
  97. Additional file 2 of VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2α
    Jiayi Yang, Yuyi Ruan, Wang, Dan, Jinjin Fan, Ning Luo, Chen, Huiting, Li, Xiaoyan, Chen, Wei, Wang, Xin · 2024 · Figshare
  98. A Switch in Iron Delivery Is Critical for Postnatal Kidney Development
    Andong Qiu, Mélanie Viltard, Rong Deng, Jacob Stauber, Aryan Ghotra, Max Werth, Christian Hinze, Andrew Beenken, Tian Huai Shen, Atlas Khan et al. · 2026 · Kidney360
  99. Serum iron as a trace element biomarker of nutritional status in nondialysis chronic kidney disease
    Evelyn Cheng, Ying-Syuan Chen, Ting‐Yun Lin, Szu‐Chun Hung · 2026 · Tzu Chi Medical Journal
  100. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions
    Anass Bouchnita · 2017